Pharmacogenetics to screen for drug-induced osteonecrosis of the jaw

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.9, 2012-07, pp. : 985-987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of drug-induced birth defects: what is known so far?

By Wilffert Bob Altena Judith Tijink Laurien van Gelder Marleen MHJ de Jong-van den Berg Lolkje TW

Pharmacogenomics, Vol. 12, Iss. 4, 2011-04 ,pp. : 547-558

Future Medicine

Access to resources Recommend Favorite

Zoledronic acid: Bisphosphonate-induced osteonecrosis of the jaw: case report

Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. : 42-42

Adis International

Access to resources Recommend Favorite

Bisphosphonate-associated risk of jaw osteonecrosis?

Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Bevacizumab: Jaw osteonecrosis: case report

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Osteonecrosis of the Jaw: An Update and Review of Recommendations

Cells Tissues Organs, Vol. 189, Iss. 1-4, 2008-09 ,pp. : 275-283

Karger

Access to resources Recommend Favorite